Moreover, the direct role of BC-associated fibroblasts in reducing hormone sensitivity and increasing resistance to endocrine therapy (i.e., Tamoxifen) has been demonstrated in ERα+ breast cancer cells [2,6]. This evidence concerns the gene ESR1 and breast carcinoma.